27(4): p
Notably, research indicates that individuals most interested in trying GLP-1 medications, and willing to accept common side effects, are those who report greater body shame, body surveillance, weight concerns, anti-fat bias, disordered eating behaviors, and higher BMIs, alongside lower body appreciation and body neutrality (Markey et al., 2025)
Type 1 diabetes: Retatrutide is not indicated for type 1 diabetes and should not be used as a substitute for insulin
Sleep hygiene is essentialmaintain regular sleep patterns, aiming for 7-9 hours nightly
T2DM generates an environment prone to atherogenesis
The article's table ranks the abdomen first because it offers the deepest and most consistent subcutaneous layer of the sites listed, which it links to the most predictable peak drug levels